Ann: Full year revenue guidance FY23, page-15

I maintain my view that there is strong support here. It’s easy to look at one side of the ledger depending on one’s bias to the stock but clearly there are over 2.8m shares on the buy side vs less than 1m shares on the sell side. Sellers are looking thinner and thinner by the day and we are up over 13% today on this news also. I understand the cautious approach in this difficult small cap market but if BIO keeps performing so well, it’s just a matter of time before the stock runs and the losers are left to BOLT.

Regardless to the punter-day traders view of things, I am very pleased to be part of such a successful company and happy to take a long view